4-Methoxy-N-(4-methyl-3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)benzamide

ID: ALA472926

PubChem CID: 24971114

Max Phase: Preclinical

Molecular Formula: C23H21N5O2

Molecular Weight: 399.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)Nc2ccc(C)c(Nc3nc(-c4cccnc4)c[nH]3)c2)cc1

Standard InChI:  InChI=1S/C23H21N5O2/c1-15-5-8-18(26-22(29)16-6-9-19(30-2)10-7-16)12-20(15)27-23-25-14-21(28-23)17-4-3-11-24-13-17/h3-14H,1-2H3,(H,26,29)(H2,25,27,28)

Standard InChI Key:  LQKJZECPLMTFEG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -2.0889   -4.0208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0901   -4.8482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3753   -5.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6588   -4.8477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6617   -4.0172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3771   -3.6080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8035   -3.6085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0563   -5.2591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7701   -4.8454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4852   -5.2568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7688   -4.0204    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8049   -5.2601    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8055   -6.0851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4761   -6.5682    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2218   -7.3530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3967   -7.3537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1413   -6.5693    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7035   -8.0179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5249   -7.9296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0102   -8.5958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6753   -9.3507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8503   -9.4354    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3687   -8.7682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4818   -6.0803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1961   -6.4916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9109   -6.0779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9070   -5.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1921   -4.8410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6266   -6.4883    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6290   -7.3133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  2  0
  4  8  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  1  0
  8  9  1  0
 18 19  2  0
  4  5  1  0
 19 20  1  0
  9 10  1  0
 20 21  2  0
  2  3  1  0
 21 22  1  0
  9 11  2  0
 22 23  2  0
 23 18  1  0
 15 18  1  0
  5  6  2  0
 10 24  2  0
  2 12  1  0
 24 25  1  0
  6  1  1  0
 25 26  2  0
 12 13  1  0
 26 27  1  0
 13 14  2  0
 27 28  2  0
 28 10  1  0
  1  2  2  0
 26 29  1  0
  1  7  1  0
 29 30  1  0
M  END

Associated Targets(Human)

FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pdgfrb Platelet-derived growth factor receptor (285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 399.45Molecular Weight (Monoisotopic): 399.1695AlogP: 4.78#Rotatable Bonds: 6
Polar Surface Area: 91.93Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.14CX Basic pKa: 7.53CX LogP: 4.24CX LogD: 3.89
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.43Np Likeness Score: -1.53

References

1. Mahboobi S, Sellmer A, Eswayah A, Elz S, Uecker A, Böhmer FD..  (2008)  Inhibition of PDGFR tyrosine kinase activity by a series of novel N-(3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)amides: a SAR study on the bioisosterism of pyrimidine and imidazole.,  43  (7): [PMID:17983688] [10.1016/j.ejmech.2007.09.021]

Source